Dose Dr
The right dose of the right medicine to the right person, at the right time, through the right route. Few health- and care providers would argue with these principles. Making sure that doses are accurately measured out and taken by patients can be challenging to do in practice, especially when administering liquid medicines to people […]
Harnessing data technologies for better diagnosis and prevention in AMR
Preventing infectious diseases and quickly and correctly diagnosing them are two key ways of minimising the burden of infectious disease on people and the need for treatment of these diseases once people have contracted them. Prevention and diagnosis are therefore cornerstones of effectively managing the wider threat of AMR. These strategies were highlighted a decade […]
NCCR AntiResist panel discussion
Antibiotic development is a notoriously complex process, with multiple scientific, regulatory, legal, financial and commercial obstacles to be considered before patients can access any successful new antibiotic. Disperazol Pharma’s CEO, Dr. Michael Graz will join Prof. Dr. Urs Jenal from NCCR AntiResist, Dr. Silke Alt from INCATE and Prof. Kevin Outterson from CARB-X to share insights about the unique challenges of […]
Disperazol to be showcased at Bionow’s 2024 BioInfect Conference
We are heading to Liverpool on 8 February to join in the discussion at the 2024 BioInfect Conference, where Michael Graz will be showcasing the potential of Disperazol as a co-treatment for UTI Infections caused by Gram negative pathogens, including E.coli and P.aeruginosa. Look out for Disperazol Pharma’s poster entitled “Boosting the efficacy of SoC antibiotics against recurrent Pseudomonas aeruginosa biofilm […]
International Day of Women and Girls in Science
The right person to do the right job at the right time in each specific situation. This is a philosophy that allows a broad and representative range of skill and expertise to be combined into the best solution to a given problem. It is also a philosophy that chimes with the aims of the International Day […]
Antibiotic resistance and climate change
It would not be an understatement to say that antimicrobial resistance (AMR) and climate change each have the power in their own right to significantly disrupt life as we currently know and experience it. Together, their potential impact is likely to be magnified exponentially, in ways that are as yet not well understood and difficult […]
MediWales Innovation Awards 2023
It was a real pleasure to present the Start Up Award to @ambrosehlthcare at the #mediwales Innovation Awards on 7 December 2023. Start-up companies are close to our heart at Biophys, so we were delighted that James Preece was able to be at the celebrations and present this award. Ambrose Healthcare is a specialist rare disease pharmaceutical company that aims to match […]
Doing the maths: Disperazol® = cystic fibrosis – (biofilms+AMR)
It was a pleasure and a privilege to attend and present the work of #Disperazol® at the 2023 North American Cystic Fibrosis Conference in Arizona from 2 to 4 November. This was our first opportunity to attend an NACFC conference and it definitely lived up to expectations. Eleven different topic tracks in the programme covered all aspects of […]
MediWales Members’ Showcase 2023
Michael Graz and James Preece are excited to be catching up with old friends and new colleagues in Cardiff at the MediWales Members’ Showcase on 11 October. They will be sharing details about some of our recent work. Join Michael and James in the morning session to find out more.
Biophys at the Nordic Innovation Fair 2023
We are really pleased to be at the Nordic Innovation Fair at Copenhagen Science City this morning where we will be presenting an update of our work with Disperazol, a novel antibiofilm compound that dismantles biofilms. Come and listen to @biophys_michael in Rooms 7&9 at 10:10 to hear more.
Fungal Diseases Awareness Week: Candida
The annual Fungal Diseases Awareness Week (18-22 September 2023) aims to highlight growing challenges, complexities, and the devastating impact of fungal diseases. We are currently working on a clinical trial protocol for the topical treatment of thrush caused by Candida albicans. Vulvovaginal candidiasis (VVC), commonly known as candidal vaginitis, thrush, or a yeast infection, is most […]
Diagnosing infectious disease – a poster child for preventive medicine if we can make the numbers work
The ravages of infectious disease would no doubt have been a concept for many people in 1948, when the NHS was born in the aftermath of WWII. Penicillin had been discovered not long before and its reputation as a wonder drug had been cemented on the battlefields of WWII. The value of a cure for […]